Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to 0.76.

  • Assembly Biosciences' Equity Ratio rose 19351.73% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 19351.73%. This contributed to the annual value of 0.28 for FY2024, which is 680.29% down from last year.
  • Latest data reveals that Assembly Biosciences reported Equity Ratio of 0.76 as of Q3 2025, which was up 19351.73% from 0.22 recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Equity Ratio peaked at 0.9 during Q3 2021, and registered a low of 0.22 during Q2 2025.
  • Over the past 5 years, Assembly Biosciences' median Equity Ratio value was 0.81 (recorded in 2022), while the average stood at 0.64.
  • As far as peak fluctuations go, Assembly Biosciences' Equity Ratio plummeted by 6790.04% in 2024, and later soared by 19351.73% in 2025.
  • Quarter analysis of 5 years shows Assembly Biosciences' Equity Ratio stood at 0.88 in 2021, then fell by 8.15% to 0.81 in 2022, then crashed by 63.01% to 0.3 in 2023, then decreased by 6.8% to 0.28 in 2024, then surged by 171.94% to 0.76 in 2025.
  • Its last three reported values are 0.76 in Q3 2025, 0.22 for Q2 2025, and 0.27 during Q1 2025.